Applying Untargeted Lipidomics to Evaluate the Efficacy of Combined Neoadjuvant Chemotherapy and Immunotherapy for Esophageal Squamous Carcinoma Treatment-Reference-Cited by-同舟云学术

Applying Untargeted Lipidomics to Evaluate the Efficacy of Combined Neoadjuvant Chemotherapy and Immunotherapy for Esophageal Squamous Carcinoma Treatment

Published:2024-01-04 Issue:2 Volume:23 Page:663-672
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Lin Weijie¹,Si Xianzhe¹,Zhao Zhihuang¹,Chen Feng¹,Xu Jie¹,Huang Wenbo¹,Lin Jianqing²,Chen Zhiyao¹,Huang Zhijun¹^ORCID

Affiliation:

1. Department of Gastrointestinal and Esophageal Surgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China

2. Department of Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China

Funder

Natural Science Foundation of Fujian Province

Quanzhou City

Fujian Province

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.3c00527

Reference29 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Oesophageal cancer

3. Update on Management of Squamous Cell Esophageal Cancer

4. Recent progress in multidisciplinary treatment for patients with esophageal cancer

5. Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Precision Medicine Approaches for Colorectal Cancer: From Molecular Profiling to Targeted Therapies;ACS Pharmacology & Translational Science;2024-03-19